Improving laboratory monitoring of medications: An economic analysis alongside a clinical trial

American Journal of Managed Care

Volumn 15, Issue 5, 2009, Pages 281-289

  Smith, David H ^a   Feldstein, Adrianne C ^a,b   Perrin, Nancy A ^a   Yang, Xiuhai ^a   Rix, Mary M ^a   Raebel, Marsha A ^a,b   Magid, David J ^a,b   Simon, Steven R ^a,c,d   Soumerai, Stephen B ^a,c,d  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD PILGRIM HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ASPARTATE AMINOTRANSFERASE; CARBAMAZEPINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; PHENYTOIN; PIOGLITAZONE; POTASSIUM; SODIUM; TERBINAFINE;

ARTICLE; BLOOD CELL COUNT; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DRUG MONITORING; ELECTRONIC MEDICAL RECORD; HEALTH CARE COST; HUMAN; LABORATORY; PATIENT CARE; PHARMACY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL;

CLINICAL LABORATORY TECHNIQUES; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DRUG MONITORING; HUMANS; PATIENT COMPLIANCE; REMINDER SYSTEMS;

EID: 66849119107     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Raebel MA, Lyons EE, Chester EA, et al. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial. Arch Intern Med. 2005;165(20):2395-2401.
2. Feldstein AC, Smith DH, Perrin N, et al. Improved therapeutic monitoring with several interventions: a randomized trial. Arch Intern Med. 2006;166(17):1848-1854.
3. National Committee for Quality Assurance. HEDIS® 2007 Summary Table of Measures and Product Lines. http://web.ncqa.Org/Portals/0/HEDISQM/ Archives/2007/MeasuresList.pdf. Accessed February 19, 2009.
4. Gold M, Siegel J, Russel L, Weinstein M. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
5. van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 1994;3(5):309~319.
6. Karnon J, Mclntosh A, Dean J, et al. Modelling the expected net benefits of interventions to reduce the burden of medication errors. J Health Serv Res Policy. 2008;13(2):85-91.
7. Lumley T, Kronmal RA, Cushman M, ManolioTA, Goldstein S. A stroke prediction score in the elderly: validation and Web-based application. J Clin Epidemiol. 2002;55(2):129-136.
8. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;8(3):341-364.
9. Forster AJ, van Walraven C. Using an interactive voice response system to improve patient safety following hospital discharge. J Eval Clin Pract. 2007;13(3):346-351.
10. Lieu TA, Capra AM, Makol J, Black SB, Shinefield HR. Effectiveness and cost-effectiveness of letters, automated telephone messages, or both for underimmunized children in a health maintenance organization. Pediatrics. 1998;101(4):E3.
11. VollmerWM, Kirshner M, Peters D, et al. Use and impact of an automated telephone outreach system for asthma in a managed care setting. Am J Manag Care. 2006;12(12):725-733.
12. Shekelle PG, Morton SC, Keeler EB. Costs and benefits of health information technology. Evid Rep Technol Assess (Full Rep). 2006;(132):1-71.
13. Chaudhry B.Wang J,Wu S, et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med. 2006;144(10):742-752.
14. Uslu AM, Stausberg J. Value of the electronic patient record: an analysis of the literature. J Biomed Inform. 2008;41 (4):675-682. Epub 2008 Feb 15.